C1GALT1C1 and breast carcinoma: We first used the CRISPR/Cas9 technology to knock out the gene encoding Cosmc, which is specifically required for the process of O‐glycosylation (Figure S2A), in two highly metastatic breast cancer cell lines (BT549, MDA‐MB‐231).